Metrics to compare | HMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.0x | −1.8x | −0.4x | |
PEG Ratio | −0.20 | 0.06 | 0.00 | |
Price/Book | 53.5x | 2.3x | 2.6x | |
Price / LTM Sales | 115.3x | 1.8x | 3.0x | |
Upside (Analyst Target) | 150.0% | 107.8% | 49.1% | |
Fair Value Upside | Unlock | 14.5% | 6.3% | Unlock |
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.